[Click to Navigate]
The value of EMTs and paramedics in the emergent care of injury and illness is undoubted. The public knows lights, sirens, and help are just a call away. However, EMS providers' unique position in the community also allows these professionals to work ahead of 9-1-1 requests—to stop injury and illness before they occur.
In the background of the current 100-year COVID-19 pandemic, another public health challenge continues—the opioid crisis. EMTs and paramedics already provide an essential safety net to individuals facing opioid use disorder. They act as a quick response to protect individuals at risk of opioid overdose and death through their normal 9-1-1 operations.
However, when communities face an inordinately high public health risk their EMS providers face a call-to-action, given their unique ability to be leveraged beyond their core focus. The opioid epidemic is one of these moments. To that end, the California Paramedic Foundation, in partnership with CVS Health, has created the California Opioid Prevention by EMS (COPE) Project to help drive EMS participation and collaboration in opioid prevention programming.
The COPE Project has two distinct programming arms. The first is the OpioidLAN, a powerful learning and action network that brings together EMS leaders from around the state. The second is the COPE Course, a free online continuing education class for EMTs and Paramedics that reviews the latest trends in the crisis, highlights ideas of harm reduction and provider self-care, and introduces a pragmatic approach to EMS-driven injury and illness prevention programming.
Great ideas and programs should never be siloed. The Opioid Learning and Action Network (OpioidLAN) is a once-a-month meeting where California EMS leaders can learn from experts in the opioid prevention space, hear from implemented programs across California, and share their programming successes or needs.
The OpioidLAN embraces the California Paramedic Foundation's risk stratification and incremental programming framework, called the RAP Toolkit. This approach supports EMS providers taking the appropriate level of public health action for their community's needs, but nothing more. This pragmatic approach to EMS prevention supports EMS's long-term involvement in the public health landscape.
Each OpioidLAN session is a light-weight, 1-hour session scheduled during the lunch hour to keep attendees' schedule impact to a minimum. Learn more about the OpioidLAN, our COPE Project Team that leads the OpioidLAN, and check our upcoming meeting schedule.
The COPE Course
The COPE Course is a free, 2-hour virtual continuing education class for California EMTs and Paramedics. It has three separate sessions, each followed by a short knowledge check.
In the first session, participants are given critical updates on the prevalence of new Fentanyl derivatives, treatment of these potent opioids, and provider safety from toxicology expert Dr. Jacob Lebin.
In the second session, participants will hear from a harm reduction specialist Kristen Marshall and Paramedic Ashley Jardine. Both session leaders share powerful ideas on harm reduction, meeting patients where they are, and thoughts on self-care as the foundation of good patient care.
EMS and prevention expert Dr. Gene Hern shares risk stratification and incremental programming approaches in the opioid prevention space in the third and final session.
California's Opioid Crisis
OpioidLAN Meeting Schedule
Session 1: April 1st, 2021 at 12p
Guest Presenter: Roneet Lev, MD, FACEP
Dr. Roneet Lev was the first Chief Medical Officer of the White House Office of National Drug Control Policy (ONDCP). She was charged with providing medical leadership in coordinating drug policy across the federal government. While working on national health policy, she continued her boots on the ground experience of over 25 years as an emergency physician treating the frontline cases of addiction.
Topic: Eliminating Stigma through clinical understanding.
Dr. Roneet Lev will kick off the OpioidLAN with a discussion on stigma and addiction. Have you been annoyed or rolled your eyes to treat yet another homeless drunk or agitated drug addict? Dr. Lev use to be that medical provider. Now she thinks of 'drugs addicts’ as people with a chronic relapsing disease of the brain, and can be my favorite type of patients. Learn about how to eliminate stigma towards addiction with medical education.
Session 2: May 19th, 2021 at 12p
Guest Presenter: Announcing soon!
Session 3: June 11th, 2021 at 12p
Guest Presenter: Announcing soon!
The COPE Team
Gene Hern, MD
Dr. Gene Hern is helps lead and facilitate the OpioidLAN portion of the COPE Project. Gene Hern received his MS in Medical Ethics from UC Berkeley in 1994 and his MD from UCSF in 1996. After residency in Emergency Medicine at Highland Hospital in Oakland in 1996. He stayed on as faculty starting in 2000. As a researcher, he has published 49 peer reviewed articles on topics as diverse as racial differences in pre-hospital opiate use to factors in transitions of care to the use of D10 in out of hospital hypoglycemia. His current focus is on quality improvement and pre hospital innovation and care of patients with Opiate Use Disorders.
John is a co-founder and Director of the California Paramedic Foundation and leads the COPE Project. John is excited for the regular and structured use of EMS in public health prevention programs. To that end, he has helped develop the ideas of risk stratification and incremental prevention programming as the foundations of EMS prevention plans. He is excited to see the propagation of EMS Prevention throughout California!
Maura serves as the coordinator of the COPE Project. Maura is currently pursuing a Masters in Biomedical Sciences and a Masters in Public Health at Tufts University in Boston, MA. She is passionate about health literacy, education, and incorporating public health principles in to emergency care. As a coordinator on the COPE project, Maura is excited to work with paramedic leaders across California and integrate EMS and public health to fight the ongoing opioid crisis.